1. Cloninger CR, Svrakic DM, Przybeck TR. A psychobiological model of temperament and character. Arch Gen Psychiatry. 1993;50(12):975-90. [ DOI:10.1001/archpsyc.1993.01820240059008] [ PMID] 2. Malayeri N, Kaviani H, Asadi S, Hoseyni F. Evaluation of personality dimensions using the Cloninger Temperament and Character Inventory in subjects with borderline personality disorders. Tehran Med Sci J. 2008;66(9):633-8. 3. Hruby R, Nosalova G, Ondrejka I, Preiss M. Personality changes during antidepressant treatment. Psychiatr Danub. 2009;21(1):25-32. [ PMID] 4. Fossati A, Cloninger CR, Villa D, Borroni S, Grazioli F, Giarolli L, et al. Reliability and validity of the Italian version of the Temperament and Character Inventory-Revised in an outpatient sample. Compr Psychiatry. 2007;48(4):380-7. [ DOI:10.1016/j.comppsych.2007.02.003] [ PMID] 5. Pournaghash Tehrani S. [Comparison of the effectiveness of methadone maintenance program on anxiety and depression symptoms of addicts]. J Psychol Stud. 2009;4(2):81-100. 6. Pournaghash Tehrani S, Nasri Tajabadi M, Yaghmaei F, Malekahmad M. [Comparison of Cognitive-emotional Dimensions of Personality in People with Psychiatric Disorders with Normal Individuals]. J Health Promot Manage. 2016;5(20):38-46. 7. Cloninger CR. A unified biosocial theory of personality and its role in the development of anxiety states. Psychiatr Dev. 1986;4(3):167-226. [ PMID] 8. Millon T, Millon C, Meagher S, Grossman S, Ramnath R. Personality Disorders in Modern Life. London: Wiley; 2004. 9. Hoseindoost F, Heshmati R. [Comparative study of temperament and character dimensions of personality in patients with major depressive disorder, bipolar I disorder and normal people]. Sci J Ilam Univ Med Sci. 2015;23(7):39-50. 10. Association AM. [Practical Guide to Depression Treatment]. Tehran: Savalan; 2010. 11. Sadock B, Sadock V. Kaplan and Sadock's Pocket Handbook of Clinical Psychiatry. 5th ed: Lippincott Williams & Wilkins; 2010. 12. Cloninger CR, Svrakic DM, Przybeck TR. Can personality assessment predict future depression? A twelve-month follow-up of 631 subjects. J Affect Disord. 2006;92(1):35-44. [ DOI:10.1016/j.jad.2005.12.034] [ PMID] 13. Hansenne M, Ansseau M. Harm avoidance and serotonin. Biol Psychol. 1999;51(1):77-81. [ DOI:10.1016/S0301-0511(99)00018-6] 14. Birt M, Vaida A, Prelipceanu D. Use of the temperament and character inventory personality questionnaire in dysthymic disorder. Hi Educ. 2006;1(1):29-34. 15. Jylha P, Isometsa E. Temperament, character and symptoms of anxiety and depression in the general population. Eur Psychiatry. 2006;21(6):389-95. [ DOI:10.1016/j.eurpsy.2005.09.003] [ PMID] 16. Tome MB, Cloninger CR, Watson JP, Isaac MT. Serotonergic autoreceptor blockade in the reduction of antidepressant latency: personality variables and response to paroxetine and pindolol. J Affect Disord. 1997;44(2-3):101-9. [ DOI:10.1016/S0165-0327(97)00030-X] 17. Farmer A, Mahmood A, Redman K, Harris T, Sadler S, McGuffin P. A sib-pair study of the Temperament and Character Inventory scales in major depression. Arch Gen Psychiatry. 2003;60(5):490-6. [ DOI:10.1001/archpsyc.60.5.490] [ PMID] 18. Mochcovitch MD, Nardi AE, Cardoso A. Temperament and character dimensions and their relationship to major depression and panic disorder. Rev Bras Psiquiatr. 2012;34(3):342-51. [ DOI:10.1016/j.rbp.2012.03.002] [ PMID] 19. Joyce PR, Mulder RT, Cloninger CR. Temperament predicts clomipramine and desipramine response in major depression. J Affect Disord. 1994;30(1):35-46. [ DOI:10.1016/0165-0327(94)90149-X] 20. Cloninger C, Thomas R, Dragan M, Richard D. The Temperament and Character Inventory (TCI): A guide to its development and use. St. Louis, MO: Center for Psychobiology of Personality, Washington University, 1994. 21. Kaneda A, Yasui-Furukori N, Nakagami T, Sato Y, Kaneko S. The influence of personality factors on paroxetine response time in patients with major depression. J Affect Disord. 2011;135(1-3):321-5. [ DOI:10.1016/j.jad.2011.06.050] [ PMID] 22. Garvey MJ, Noyes R, Cook B, Blum N. Preliminary confirmation of the proposed link between reward-dependence traits and norepinephrine. Psychiatry Res. 1996;65(1):61-4 [ DOI:10.1016/0165-1781(96)02954-X] 23. Elovainio M, Kivimaki M, Steen N, Vahtera J. Job decision latitude, organizational justice and health: multilevel covariance structure analysis. Soc Sci Med. 2004;58(9):1659-69. [ DOI:10.1016/S0277-9536(03)00366-6] 24. Fava M, Kendler KS. Major depressive disorder. Neuron. 2000;28(2):335-41. [ DOI:10.1016/S0896-6273(00)00112-4] 25. Julien RM. A primer of drug action: A concise nontechnical guide to the actions, uses, and side effects of psychoactive drugs, revised and updated. New York: Worth Publishers; 2008. 26. Antelman SM, Caggiula AR. Norepinephrine-dopamine interactions and behavior. Science. 1977;195(4279):646-53. [ DOI:10.1126/science.841304] 27. Sher KJ, Bartholow BD, Wood MD. Personality and substance use disorders: a prospective study. J Consult Clin Psychol. 2000;68(5):818-29. [ DOI:10.1037/0022-006X.68.5.818] [ PMID] 28. Daw ND, Kakade S, Dayan P. Opponent interactions between serotonin and dopamine. Neural Netw. 2002;15(4-6):603-16. [ DOI:10.1016/S0893-6080(02)00052-7] 29. Guiard BP, El Mansari M, Merali Z, Blier P. Functional interactions between dopamine, serotonin and norepinephrine neurons: an in-vivo electrophysiological study in rats with monoaminergic lesions. Int J Neuropsychopharmacol. 2008;11 (5):625-39. [ DOI:10.1017/S1461145707008383] [ PMID] 30. Yıldız A, Gönül AS, Tamam L. Mechanism of actions of antidepressants: beyond the receptors. Bullet Clin Psychopharmacol. 2002;12(4):194-200. 31. Zald DH, Cowan RL, Riccardi P, Baldwin RM, Ansari MS, Li R, et al. Midbrain dopamine receptor availability is inversely associated with novelty-seeking traits in humans. J Neurosci. 2008;28 (53):14372-8. [ DOI:10.1523/JNEUROSCI.2423-08.2008] [ PMID] [ PMCID] 32. Adan A, Serra-Grabulosa JM, Caci H, Natale V. A reduced Temperament and Character Inventory (TCI-56). Psychometric properties in a non-clinical sample. Pers Individ Differ. 2009;46(7):687-92. [ DOI:10.1016/j.paid.2009.01.023] 33. Asnis GM, Wetzler S, Sanderson WC, Kahn RS, van Praag HM. Functional interrelationship of serotonin and norepinephrine: cortisol response to MCPP and DMI in patients with panic disorder, patients with depression, and normal control subjects. Psychiatry Res. 1992;43(1):65-76. [ DOI:10.1016/0165-1781(92)90142-P] 34. Borg J, Andree B, Soderstrom H, Farde L. The serotonin system and spiritual experiences. Am J Psychiatry. 2003;160(11):1965-9. [ DOI:10.1176/appi.ajp.160.11.1965] [ PMID] 35. Wade A, Michael Lemming O, Bang Hedegaard K. Escitalopram 10 mg/day is effective and well tolerated in a placebo-controlled study in depression in primary care. Int Clin Psychopharmacol. 2002;17(3):95-102. [ DOI:10.1097/00004850-200205000-00001] [ PMID]
|